Best Mid Cap Companies To Buy For 2015

Dividend investors would be wise to focus not just on a stock's current yield, but also on the long-term growth potential of its dividends. That's because strong businesses that consistently raise their dividend payouts reward shareholders with a steadily rising income stream that essentially equates to a raise every year. And, well, who doesn't like a raise?

But there are other reasons to value dividend growth so highly, and they're well supported by research. For instance, a study by C. Thomas Howard published in Advisor Perspectives found that for every percentage point a stock's yield rises, its annual return increases by 0.22 percentage points if it's a large cap, 0.25 if it's a mid cap, and 0.46 if it's a small cap. Even better, Howard found that dividend-growing stocks outperformed dividend cutters by 10 percentage points per year from 1973 to 2010 and beat both flat- and no-dividend stocks. And the icing on the cake is that Howard showed that this outperformance came with a third less volatility. Higher returns, less volatility-induced stress, and a steadily growing income stream -- what's not to love?

Top 5 Retail Stocks For 2016: Excel Trust Inc (EXL)

Excel Trust, Inc., incorporated on December 15, 2009, is a vertically integrated, self-administered, self-managed real estate investment trust (REIT). The Company�� principal objective is to acquire, finance, develop, lease, own and manage value-oriented community and power centers, grocery anchored neighborhood centers and freestanding retail properties. The Company conducts all of its business through Excel Trust, L.P., a limited partnership, or its operating partnership. The Company operates through three reportable business segments: retail properties, multi-family properties and office properties. The multi-family segment consists of apartment units at one retail property, West Broad Village, which is located in Richmond, Virginia. The office segment consists of two properties, Excel Centre, a portion of which is utilized as its headquarters, and the Promenade Corporate Center. The Company is the sole general partner of its operating partnership. Excel Trust leases its properties to national and regional supermarket chains, big-box retailers and select national retailers that offer necessity and value oriented items and generate regular consumer traffic. In October 2012, the Company acquired six shopping centers. On January 24, 2013, the Company completed the acquisition of Tracy Pavilion, a retail shopping center with approximately 162,000 square feet of gross leasable area located in Tracy, California. In September 2013, the Company announced the sale of Grant Creek Town Center.

As of December 31, 2012, the Company owned a portfolio consisting of 30 retail properties totaling approximately 5.1 million square feet of gross leasable area, which were approximately 93.4% leased. The Company owns two commercial office properties, Excel Center, a portion of which is utilized as its corporate headquarters, and the Promenade Corporate Center. As of December 31, 2012, the Company had ownership interests in two unconsolidated retail properties totaling 225,113 square feet of gross leasable! area, which were approximately 65.5% leased.

Advisors' Opinion:

• [By Marc Bastow]

  Commercial and retail property owner-operator and real estate investment trust Excel Trust (EXL) raised its quarterly dividend 3% to 17.5 cents per share, payable on Jan. 15 to shareholders of record as of Dec. 31.
  EXL Dividend Yield: 6.04%
  

Best Mid Cap Companies To Buy For 2015: UnipolSai Assicurazioni SpA (US)

UnipolSai Assicurazioni SpA, formerly Fondiaria SPA, is an Italy- based company engaged in financial sector. The Company is a result of the merger of Unipol Assicurazioni SpA, Milano Assicurazioni SpA and Premafin Finanziaria SpA into Fondiaria Sai SpA. The Company operates through approximately 3 000 agencies under brands, such as Unipol, Sai, La Fondaria, Milano, La Previdente, Nuova Maa and Sasa. UnipolSai Assicurazioni SpA specializes in non-life insurance, especially automobile insurance. Additionally, UnipolSai Assicurazioni SpA provides products which protect its clients against damage and accident in the field, such as work, home, travel, health, life, aviation, railway, fire, maritime and goods in transit, as well as reinsurance and legal protection. Advisors' Opinion:

• [By John Heinzl]

  The company also provides the tax breakdown on its Web site. For example, in 2012, the partnership distributed $1.50 (US) per unit to investors, or $1.4988 (Canadian). (The company��hich owns a global portfolio of utility, energy, and transportation infrastructure assets��ays distributions in US currency, but it also provides the tax breakdown in Canadian dollars.)

Best Mid Cap Companies To Buy For 2015: Pacific Rubiales Energy Corp (PEGFF.PK)

Pacific Rubiales Energy Corp. (Pacific Rubiales) is a producerand seller of natural gas and heavy crude oil. The Company also purchases crude oil from third parties to be used as diluents and for trading purposes. The Company owns Meta Petroleum Corp. (Meta), an oil branch which operates the Rubiales/Piriri and Quifa oil fields in the Llanos Basin in association with Ecopetrol; and Pacific Stratus Energy Colombia Corp. (Pacific Stratus), which operates the wholly owned La Creciente gas field in the northern part of Colombia and other light and medium oil fields. In addition to its production assets, it has investment in oil pipelines in Colombia, including the Oleoducto de los Llanos S.A. Pipeline and the new Oleoducto Bicentenario de Colombia pipeline, under construction. In November 2013, Pacific Rubiales Energy Corp acquired Petrominerales Ltd. Advisors' Opinion:

• [By Value Digger]

  C&C Energia was acquired by Pacific Rubiales (PEGFF.PK) for $9.5 (including the shares for Platino Energy), three months later. Nobody else had ever written an online article about C&C Energia.

Best Mid Cap Companies To Buy For 2015: Petrosonic Energy Inc (PSON)

Petrosonic Energy, Inc, incorporated on June 11, 2008, is a development-stage company. The Company focused on the treatment and upgrading of heavy oil by sonicated solvent de-asphalting. On July 27, 2012, the Company completed the acquisition of 60% ownership in Petrosonic Albania, SHA. from Sonoro.

The Company�� core technology is an industrial scale sonic reactor that transfers sonic energy on an industrial scale to physical, chemical or biological processes. As of December 31, 2012, the Company had not generated any revenue.

Advisors' Opinion:

• [By Inyoung Hwang]

  Pearson (PSON) jumped 6.2 percent to 1,329 pence, the highest price since May 2001. The media and education company said first-half revenue climbed 7 percent to 2.76 billion pounds ($4.3 billion), surpassing the 2.69 billion-pound average prediction of analysts. Profit fell 26 percent as the company invested in new products.

• [By Namitha Jagadeesh]

  Pearson Plc (PSON) surged 6.2 percent to 1,329 pence, its highest price since 2001. The publisher of the Financial Times newspaper posted first-half sales of 2.76 billion pounds ($4.2 billion), exceeding the 2.69 billion pounds estimated by analysts in a Bloomberg survey.

Best Mid Cap Companies To Buy For 2015: Medbox Inc (MDBX.PK)

Medbox Inc. (Medbox) offers a machine that dispenses medication to individuals based on biometric identification (fingerprint sample). The machine allows pharmacies, hospitals, doctors' offices, and alternative medicine clinics to manage employee possession of sensitive drugs. The system also allows these clinics to demonstrate that the user visiting the machine is a registered patient and that the patient has a valid and unexpired authorization from a physician to possess and use the medicine dispensed. The Company has national and international presence with offices in Los Angeles, New York, Toronto, London and Tokyo.

Medbox, through its subsidiaries, offers consulting services to the alternative medicine industry, as well as to the mini self-storage market. The Company provides consulting services primarily to individuals and groups seeking to establish new clinics and facilities, often in jurisdictions that have recently passed legislation concerning th e availability of alternative medicines, as well as existing jurisdictions, nationwide.

Advisors' Opinion:

• [By Alan Brochstein]

  Taking into account all of the data I have shared, I want to introduce my take on the most important names to follow. My initial list takes into account not only the market cap, but also business model and interest level. These are the stocks that I think merit the most attention (in alphabetical order):

  CannaVest (CANV.OB)GW Pharma (GWPH)MedBox (MDBX.PK)Medical Marijuana, Inc. (MJNA.PK)

  CANV doesn't really trade, as it is held closely by insiders (99.7%, including MJNA). I have a few concerns, including the valuation and some near-term financial challenges typical of a start-up with just one client looking to expand its customer base, but I like the focus and the fact that it is an SEC filer with a relatively clean history (i.e. none of the baggage of some of these other companies). I have spoken to its outsourced CFO and am impressed by his background (has been CFO or held key financial roles at publicly-traded healthcare companies). CANV is the partner to MJNA that is responsible for manufacturing the CBD (Cannibidiol, the cannabinoid in marijuana that is increasingly viewed as offering substantial medical benefits). I am very concerned about the near-term financials, but this is a pure-play with probably a two-year lead over other companies. I don't see a moat in terms of intellectual property or brands, but they have a good lead in terms of sourcing of supply and penetration into potential customers. Quite simply, they don't appear to have competition at present. The company, then, is a call option on CBD demand taking off. It appears that it could be a supplier to even Big Pharma should medical marijuana research move into the mainstream.

Best Mid Cap Companies To Buy For 2015: Vertex Pharmaceuticals Incorporated(VRTX)

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for the treatment of serious diseases worldwide. Its products include telaprevir, a prescription medicine used for the treatment of patients with genotype 1 hepatitis C virus (HCV) infection; and Ivacaftor, a prescription medicine used for the treatment of cystic fibrosis. The company markets its products under the INCIVEK brand name in the United States and Canada; INCIVO brand in the United Kingdom, Germany, France, Sweden, Austria, Finland, Denmark, Switzerland, and Norway; KALYDECO brand in the United States; and TELAVIC brand in Japan. Its drug candidates comprise VX-222, a Phase II clinical trial drug candidate, and ALS-2200 and ALS-2158, a Phase I clinical trial drug candidates that are designed to inhibit the replication of HCV; VX-809 and VX-661, a Phase II clinical trial drug candidates that improve the function of defective cystic fibro sis; VX-509, a Phase II clinical trial drug candidate for the treatment of patients with rheumatoid arthritis and other immune-mediated inflammatory diseases; VX-765, a Phase II clinical trial drug for the treatment of epilepsy; and VX-787, an investigational drug candidate for the treatment of influenza A. The company was founded in 1989 and is headquartered in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Ben Levisohn]

  Vertex Pharmaceuticals (VRTX) popped 9.2% to $71.04 this week. The Street.com’s Adam Feuerstein predicted the Vertex’s cystic fibrosis drug would be successful in clinical trials.

• [By Brian Orelli]

  As for new drugs, watch Incivo, which Johnson & Johnson sells abroad for�Vertex Pharmaceuticals (NASDAQ: VRTX  ) . While U.S. sales of Vertex's hepatitis C drug -- called Incivek stateside -- have slumped as patients wait for newer medications, sales outside the U.S. continue to increase, benefiting both Johnson & Johnson and Vertex, which receives a royalty on sales.

• [By Ben Levisohn]

  Stocks bucked their recent Monday weakness today as Visa (V), International Business Machines (IBM), United Technologies (UTX), Micron Technology (MU) and Vertex Pharmaceuticals (VRTX) gained. But your view of today likely depended on the index you were watching.